|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.767
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.406
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.397
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.356
|
|
|
|
positive regulation of interleukin 8 secretion
|
GO:2000484 |
1 |
0.356
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.350
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.337
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.304
|
|
|
|
nephric duct formation
|
GO:0072179 |
4 |
0.303
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.275
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.260
|
|
|
|
mesonephric duct formation
|
GO:0072181 |
2 |
0.259
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.241
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.231
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.231
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.230
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.229
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.228
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.224
|
|
|
|
planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:0061347 |
2 |
0.220
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.220
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.198
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.196
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.196
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.196
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.196
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.191
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.191
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.184
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.182
|
|
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.181
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.177
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.175
|
|
|
|
myoblast differentiation involved in skeletal muscle regeneration
|
GO:0014835 |
3 |
0.174
|
|
|
|
lung induction
|
GO:0060492 |
3 |
0.173
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.172
|
|
|
|
regulation of testosterone biosynthetic process
|
GO:2000224 |
2 |
0.169
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.162
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.162
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.160
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.155
|
|
|
|
metanephric epithelium development
|
GO:0072207 |
21 |
0.151
|
|
|
|
mesonephric duct morphogenesis
|
GO:0072180 |
4 |
0.149
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.148
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.145
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.142
|
|
|
|
planar cell polarity pathway involved in pericardium morphogenesis
|
GO:0061354 |
2 |
0.140
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.140
|
|
|
|
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis
|
GO:0061350 |
2 |
0.139
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.138
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.138
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.138
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.136
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.135
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.134
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.132
|
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.130
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.128
|
|
|
|
planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:0061349 |
2 |
0.128
|
|
|
|
spemann organizer formation at the anterior end of the primitive streak
|
GO:0060064 |
1 |
0.127
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.126
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.126
|
|
|
|
regulation of cell cell adhesion mediated by cadherin
|
GO:2000047 |
2 |
0.125
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.122
|
|
|
|
planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:0061348 |
2 |
0.122
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.122
|
|
|
|
central nervous system vasculogenesis
|
GO:0022009 |
3 |
0.121
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.120
|
|
|
|
ubiquitin dependent smad protein catabolic process
|
GO:0030579 |
2 |
0.119
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.114
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.113
|
|
|
|
wnt signaling pathway involved in kidney development
|
GO:0061289 |
2 |
0.113
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.113
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.113
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.111
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.110
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.109
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.109
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.107
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.104
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.104
|
|
|
|
negative regulation of androgen biosynthetic process
|
GO:2000180 |
1 |
0.103
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.103
|
|
|
|
positive regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:0060501 |
3 |
0.101
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.101
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.101
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.100
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.100
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.100
|
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.099
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.099
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.098
|
|
|
|
negative regulation of testosterone biosynthetic process
|
GO:2000225 |
1 |
0.098
|
|
|
|
metanephric nephron epithelium development
|
GO:0072243 |
19 |
0.096
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.096
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.095
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.094
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.093
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.093
|
|
|
|
androgen biosynthetic process
|
GO:0006702 |
4 |
0.093
|
|
|
|
cell cell adhesion via plasma membrane adhesion molecules
|
GO:0098742 |
40 |
0.092
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.092
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.092
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.091
|
|
|
|
oxygen homeostasis
|
GO:0032364 |
2 |
0.090
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.089
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.089
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.088
|
|
|
|
keratinocyte migration
|
GO:0051546 |
3 |
0.087
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.087
|
|
|
|
inner medullary collecting duct development
|
GO:0072061 |
2 |
0.086
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.086
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.086
|
|
|
|
renal sodium excretion
|
GO:0035812 |
3 |
0.085
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.085
|
|
|
|
trachea cartilage morphogenesis
|
GO:0060535 |
4 |
0.085
|
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.084
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.084
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.084
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.083
|
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
59 |
0.083
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.082
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.081
|
|
|
|
positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000081 |
1 |
0.081
|
|
|
|
dna templated transcriptional preinitiation complex assembly
|
GO:0070897 |
4 |
0.080
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.079
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.078
|
|
|
|
testosterone biosynthetic process
|
GO:0061370 |
2 |
0.078
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.077
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.077
|
|
|
|
planar cell polarity pathway involved in heart morphogenesis
|
GO:0061346 |
3 |
0.077
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.076
|
|
|
|
platelet aggregation
|
GO:0070527 |
20 |
0.076
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.075
|
|
|
|
midbrain hindbrain boundary maturation
|
GO:0021732 |
1 |
0.075
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.075
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.074
|
|
|
|
establishment of organ orientation
|
GO:0048561 |
1 |
0.074
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.074
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.074
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.074
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.073
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.073
|
|
|
|
cardiac right atrium morphogenesis
|
GO:0003213 |
3 |
0.072
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.072
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.072
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.072
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.072
|
|
|
|
lateral sprouting involved in mammary gland duct morphogenesis
|
GO:0060599 |
2 |
0.071
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.070
|
|
|
|
nk t cell proliferation
|
GO:0001866 |
2 |
0.070
|
|
|
|
positive regulation of cell cell adhesion mediated by cadherin
|
GO:2000049 |
2 |
0.069
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.069
|
|
|
|
potassium ion transport
|
GO:0006813 |
52 |
0.069
|
|
|
|
interleukin 8 secretion
|
GO:0072606 |
3 |
0.068
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.068
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.068
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.068
|
|
|
|
regulation of steroid biosynthetic process
|
GO:0050810 |
26 |
0.067
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.067
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.067
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.067
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.066
|
|
|
|
cop9 signalosome assembly
|
GO:0010387 |
2 |
0.065
|
|
|
|
renal inner medulla development
|
GO:0072053 |
3 |
0.065
|
|
|
|
positive regulation of transforming growth factor beta2 production
|
GO:0032915 |
2 |
0.065
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.065
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.065
|
|
|
|
wnt signaling pathway involved in forebrain neuroblast division
|
GO:0021874 |
2 |
0.064
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.064
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.064
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.064
|
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.063
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.063
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.063
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.063
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.063
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.062
|
|
|
|
regulation of ketone biosynthetic process
|
GO:0010566 |
2 |
0.062
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.062
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.062
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.062
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.062
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.061
|
|
|
|
adenylate cyclase inhibiting g protein coupled receptor signaling pathway
|
GO:0007193 |
20 |
0.061
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.061
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.061
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.061
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.060
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.060
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.060
|
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.059
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.059
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.059
|
|
|
|
steroid biosynthetic process
|
GO:0006694 |
47 |
0.059
|
|
|
|
non canonical wnt signaling pathway via mapk cascade
|
GO:0038030 |
3 |
0.059
|
|
|
|
canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation
|
GO:0044343 |
1 |
0.058
|
|
|
|
uterus morphogenesis
|
GO:0061038 |
2 |
0.058
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.058
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.058
|
|
|
|
actin filament bundle assembly
|
GO:0051017 |
40 |
0.058
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.058
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.058
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.057
|
|
|
|
lobar bronchus development
|
GO:0060482 |
6 |
0.057
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.057
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.057
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.057
|
|
|
|
sensory perception of taste
|
GO:0050909 |
18 |
0.056
|
|
|
|
gas homeostasis
|
GO:0033483 |
3 |
0.056
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.056
|
|
|
|
establishment of anatomical structure orientation
|
GO:0048560 |
1 |
0.056
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.056
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.055
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.055
|
|
|
|
metanephric nephron tubule development
|
GO:0072234 |
16 |
0.054
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.054
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.054
|
|
|
|
positive regulation of blood circulation
|
GO:1903524 |
22 |
0.054
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.054
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.054
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.054
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.054
|
|
|
|
outer medullary collecting duct development
|
GO:0072060 |
1 |
0.053
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.053
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.053
|
|
|
|
cell cell signaling involved in kidney development
|
GO:0060995 |
2 |
0.053
|
|
|
|
positive regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045899 |
2 |
0.053
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.053
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.052
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.052
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.052
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.051
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.051
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.051
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.051
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.050
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.050
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.050
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.050
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.049
|
|
|
|
metanephric tubule development
|
GO:0072170 |
18 |
0.049
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.049
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.049
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.048
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.048
|
|
|
|
platelet activation
|
GO:0030168 |
40 |
0.048
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.048
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.048
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.047
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.047
|
|
|
|
natural killer cell proliferation
|
GO:0001787 |
3 |
0.047
|
|
|
|
hexose transport
|
GO:0008645 |
56 |
0.047
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.047
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.047
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.047
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.047
|
|
|
|
morphogenesis of an epithelial sheet
|
GO:0002011 |
27 |
0.046
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.046
|
|
|
|
leukocyte chemotaxis
|
GO:0030595 |
69 |
0.046
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.046
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.046
|
|
|
|
regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000079 |
1 |
0.046
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.046
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.046
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.045
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.045
|
|
|
|
endoderm development
|
GO:0007492 |
45 |
0.045
|
|
|
|
tertiary branching involved in mammary gland duct morphogenesis
|
GO:0060748 |
3 |
0.045
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.045
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.045
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.045
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.044
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.044
|
|
|
|
hindbrain formation
|
GO:0021576 |
1 |
0.044
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.044
|
|
|
|
positive regulation of ion transport
|
GO:0043270 |
65 |
0.044
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.043
|
|
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.043
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.043
|
|
|
|
spemann organizer formation
|
GO:0060061 |
2 |
0.043
|
|
|
|
pigment metabolic process
|
GO:0042440 |
32 |
0.043
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.043
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.043
|
|
|
|
cellular response to parathyroid hormone stimulus
|
GO:0071374 |
2 |
0.043
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.043
|
|
|
|
kidney rudiment formation
|
GO:0072003 |
3 |
0.042
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.042
|
|
|
|
establishment of planar polarity involved in nephron morphogenesis
|
GO:0072046 |
1 |
0.042
|
|
|
|
cofactor metabolic process
|
GO:0051186 |
80 |
0.042
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.042
|
|
|
|
sialylation
|
GO:0097503 |
14 |
0.042
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.042
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.042
|
|
|
|
establishment of endothelial blood brain barrier
|
GO:0014045 |
3 |
0.041
|
|
|
|
vitamin metabolic process
|
GO:0006766 |
23 |
0.041
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.041
|
|
|
|
positive regulation of branching involved in lung morphogenesis
|
GO:0061047 |
4 |
0.041
|
|
|
|
cell cell signaling involved in metanephros development
|
GO:0072204 |
2 |
0.041
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.041
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.041
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.040
|
|
|
|
antigen receptor mediated signaling pathway
|
GO:0050851 |
64 |
0.040
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.040
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.040
|
|
|
|
cellular phosphate ion homeostasis
|
GO:0030643 |
2 |
0.040
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.040
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.040
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.040
|
|
|
|
vitamin d3 metabolic process
|
GO:0070640 |
3 |
0.039
|
|
|
|
apoptotic process involved in patterning of blood vessels
|
GO:1902262 |
6 |
0.039
|
|
|
|
lung field specification
|
GO:0060424 |
3 |
0.039
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.039
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.039
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.039
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.039
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.038
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.038
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.038
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.038
|
|
|
|
potassium ion transmembrane transport
|
GO:0071805 |
43 |
0.038
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.038
|
|
|
|
wnt signaling pathway calcium modulating pathway
|
GO:0007223 |
2 |
0.038
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.037
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.037
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.037
|
|
|
|
columnar cuboidal epithelial cell development
|
GO:0002066 |
29 |
0.037
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.037
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.036
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.036
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.036
|
|
|
|
cellular potassium ion transport
|
GO:0071804 |
43 |
0.036
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.036
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.036
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
58 |
0.036
|
|
|
|
response to retinoic acid
|
GO:0032526 |
56 |
0.036
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.036
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.036
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.036
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.036
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.035
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.035
|
|
|
|
positive regulation of stress activated mapk cascade
|
GO:0032874 |
48 |
0.035
|
|
|
|
nephric duct morphogenesis
|
GO:0072178 |
7 |
0.035
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.035
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.035
|
|
|
|
regulation of atp metabolic process
|
GO:1903578 |
17 |
0.035
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.035
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.035
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.035
|
|
|
|
negative regulation of reproductive process
|
GO:2000242 |
31 |
0.034
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.034
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.034
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.034
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.034
|
|
|
|
hematopoietic stem cell proliferation
|
GO:0071425 |
13 |
0.034
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
57 |
0.034
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.034
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.034
|
|
|
|
bronchus development
|
GO:0060433 |
10 |
0.034
|
|
|
|
establishment of planar polarity of embryonic epithelium
|
GO:0042249 |
16 |
0.034
|
|
|
|
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration
|
GO:0014834 |
3 |
0.034
|
|
|
|
establishment of planar polarity involved in neural tube closure
|
GO:0090177 |
15 |
0.034
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.033
|
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.033
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.033
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.033
|
|
|
|
atp catabolic process
|
GO:0006200 |
55 |
0.033
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.033
|
|
|
|
midbrain hindbrain boundary maturation during brain development
|
GO:0022004 |
1 |
0.033
|
|
|
|
endodermal cell fate commitment
|
GO:0001711 |
12 |
0.032
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.032
|
|
|
|
pilomotor reflex
|
GO:0097195 |
3 |
0.032
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.032
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.032
|
|
|
|
polarity specification of proximal distal axis
|
GO:0010085 |
2 |
0.032
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.032
|
|
|
|
fc receptor mediated inhibitory signaling pathway
|
GO:0002774 |
1 |
0.032
|
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.032
|
|
|
|
interferon gamma production
|
GO:0032609 |
67 |
0.032
|
|
|
|
metanephric nephron development
|
GO:0072210 |
34 |
0.032
|
|
|
|
transforming growth factor beta2 production
|
GO:0032906 |
2 |
0.032
|
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
57 |
0.031
|
|
|
|
lung alveolus development
|
GO:0048286 |
45 |
0.031
|
|
|
|
regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045898 |
2 |
0.031
|
|
|
|
fibroblast growth factor production
|
GO:0090269 |
4 |
0.031
|
|
|
|
positive regulation of stress fiber assembly
|
GO:0051496 |
9 |
0.031
|
|
|
|
immune response regulating cell surface receptor signaling pathway
|
GO:0002768 |
80 |
0.031
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.031
|
|
|
|
metanephric glomerular epithelial cell development
|
GO:0072313 |
2 |
0.031
|
|
|
|
regulation of transforming growth factor beta2 production
|
GO:0032909 |
2 |
0.031
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.031
|
|
|
|
positive regulation of megakaryocyte differentiation
|
GO:0045654 |
4 |
0.031
|
|
|
|
positive regulation of actin filament bundle assembly
|
GO:0032233 |
11 |
0.031
|
|
|
|
regulation of cardioblast differentiation
|
GO:0051890 |
3 |
0.031
|
|
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.031
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.030
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.030
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.030
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.030
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.030
|
|
|
|
lung epithelium development
|
GO:0060428 |
37 |
0.030
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.030
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.030
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.030
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.030
|
|
|
|
regulation of mast cell proliferation
|
GO:0070666 |
4 |
0.030
|
|
|
|
cerebellum formation
|
GO:0021588 |
1 |
0.030
|
|
|
|
positive regulation of vasoconstriction
|
GO:0045907 |
4 |
0.030
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.030
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.030
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.030
|
|
|
|
rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0051123 |
3 |
0.030
|
|
|
|
endodermal cell fate determination
|
GO:0007493 |
2 |
0.030
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.030
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.030
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.029
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.029
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.029
|
|
|
|
regulation of fibroblast growth factor production
|
GO:0090270 |
4 |
0.029
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.029
|
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
61 |
0.029
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.029
|
|
|
|
positive regulation of jnk cascade
|
GO:0046330 |
46 |
0.029
|
|
|
|
alanine transport
|
GO:0032328 |
4 |
0.029
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.029
|
|
|
|
non canonical wnt signaling pathway involved in heart development
|
GO:0061341 |
3 |
0.028
|
|
|
|
cochlea morphogenesis
|
GO:0090103 |
22 |
0.028
|
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.028
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.028
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.028
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.028
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.028
|
|
|
|
metanephric glomerular epithelium development
|
GO:0072244 |
3 |
0.028
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.028
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.028
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.028
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.028
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.028
|
|
|
|
establishment or maintenance of polarity of embryonic epithelium
|
GO:0016332 |
1 |
0.027
|
|
|
|
regulation of definitive erythrocyte differentiation
|
GO:0010724 |
3 |
0.027
|
|
|
|
regulation of ureteric bud formation
|
GO:0072106 |
3 |
0.027
|
|
|
|
positive regulation of intracellular estrogen receptor signaling pathway
|
GO:0033148 |
4 |
0.027
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
64 |
0.027
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.027
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.027
|
|
|
|
positive regulation of interleukin 13 production
|
GO:0032736 |
4 |
0.027
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.027
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.027
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.027
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
50 |
0.027
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.027
|
|
|
|
canonical wnt signaling pathway involved in metanephric kidney development
|
GO:0061290 |
2 |
0.027
|
|
|
|
peptide metabolic process
|
GO:0006518 |
46 |
0.027
|
|
|
|
protein autoprocessing
|
GO:0016540 |
2 |
0.027
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.027
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.027
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.026
|
|
|
|
negative regulation of protein serine threonine kinase activity
|
GO:0071901 |
49 |
0.026
|
|
|
|
regulation of anagen
|
GO:0051884 |
1 |
0.026
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.026
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.026
|
|
|
|
regulation of myeloid leukocyte mediated immunity
|
GO:0002886 |
25 |
0.026
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.026
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.026
|
|
|
|
cochlea development
|
GO:0090102 |
35 |
0.026
|
|
|
|
cell cell adhesion
|
GO:0098609 |
41 |
0.026
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.026
|
|
|
|
maintenance of cell number
|
GO:0098727 |
3 |
0.026
|
|
|
|
anatomical structure maturation
|
GO:0071695 |
49 |
0.026
|
|
|
|
regulation of thyroid hormone generation
|
GO:2000609 |
4 |
0.026
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.026
|
|
|
|
canonical wnt signaling pathway involved in regulation of cell proliferation
|
GO:0044340 |
3 |
0.026
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.025
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.025
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.025
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.025
|
|
|
|
response to estrogen
|
GO:0043627 |
24 |
0.025
|
|
|
|
regulation of toll like receptor 4 signaling pathway
|
GO:0034143 |
4 |
0.025
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.025
|
Mouse |
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.025
|
|
|
|
detection of stimulus involved in sensory perception
|
GO:0050906 |
44 |
0.025
|
|
|
|
hypophysis morphogenesis
|
GO:0048850 |
3 |
0.025
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.025
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.025
|
|
|
|
alcohol biosynthetic process
|
GO:0046165 |
43 |
0.025
|
|
|
|
mesonephric tubule formation
|
GO:0072172 |
11 |
0.025
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.025
|
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
55 |
0.025
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.025
|
|
|
|
renal outer medulla development
|
GO:0072054 |
2 |
0.025
|
|
